Related references
Note: Only part of the references are listed.The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma
Hong Gao et al.
FRONTIERS IN ONCOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
Xin Hu et al.
NATURE COMMUNICATIONS (2021)
Analysis of the Prognostic Value and Gene Expression Mechanism of SHOX2 in Lung Adenocarcinoma
Nanhong Li et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer
Nanhong Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
Xing Hua et al.
NATURE COMMUNICATIONS (2020)
Performance Evaluation of SHOX2 and RASSF1A Methylation for the Aid in Diagnosis of Lung Cancer Based on the Analysis of FFPE Specimen
Juanhong Shi et al.
FRONTIERS IN ONCOLOGY (2020)
Early-Stage NSCLC: Advances in Thoracic Oncology 2018
Raymond U. Osarogiagbon et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Genetic and epigenetic alterations of the EGFR and mutually independent association with BRCA1, MGMT, and RASSF1A methylations in Vietnamese lung adenocarcinomas
Quang Ngoc Nguyen et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
Vincent Dochez et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer
Yuhai Bao et al.
SURGICAL ONCOLOGY-OXFORD (2019)
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu et al.
NATURE COMMUNICATIONS (2019)
Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma
Chao Zhang et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Genomic and immune profiling of pre-invasive lung adenocarcinoma
Haiquan Chen et al.
NATURE COMMUNICATIONS (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis
M. Lee Schmidt et al.
CANCER RESEARCH (2018)
CT features differentiating pre- and minimally invasive from invasive adenocarcinoma appearing as mixed ground-glass nodules: mass is a potential imaging biomarker
X. -W. Wang et al.
CLINICAL RADIOLOGY (2018)
Single-Cell DNA Methylation Profiling: Technologies and Biological Applications
Ino D. Karemaker et al.
TRENDS IN BIOTECHNOLOGY (2018)
Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
Gunter Weiss et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Translating cancer epigenomics into the clinic: focus on lung cancer
Josep Mari-Alexandre et al.
TRANSLATIONAL RESEARCH (2017)
Progress and prospects of early detection in lung cancer
Sean Blandin Knight et al.
OPEN BIOLOGY (2017)
DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis
Chenzi Zhang et al.
JOURNAL OF CANCER (2017)
Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis
Minpu Ren et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2017)
RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway
Fatemeh Dubois et al.
CANCER RESEARCH (2016)
Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study
Ryutaro Kakinuma et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Clinical utility of RASSF1A methylation in human malignancies
A. M. Grawenda et al.
BRITISH JOURNAL OF CANCER (2015)
DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors
Tali Mazor et al.
CANCER CELL (2015)
Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts
Miguel Vizoso et al.
CARCINOGENESIS (2015)
Lineage factors and differentiation states in lung cancer progression
W. K. C. Cheung et al.
ONCOGENE (2015)
Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis
Qing-Tao Zhao et al.
ONCOTARGETS AND THERAPY (2015)
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
Evgeny Izumchenko et al.
NATURE COMMUNICATIONS (2015)
Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth
Y. Kobayashi et al.
ANNALS OF ONCOLOGY (2015)
RASSF1A Inactivation Unleashes a Tumor Suppressor/Oncogene Cascade with Context-Dependent Consequences on Cell Cycle Progression
Rosalyn R. Ram et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer
David Brocks et al.
CELL REPORTS (2014)
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Edward F. Patz et al.
JAMA INTERNAL MEDICINE (2014)
Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging
K. Darwiche et al.
ANNALS OF ONCOLOGY (2013)
Genome-wide CpG island methylation analyses in non-small cell lung cancer patients
Gerwin Heller et al.
CARCINOGENESIS (2013)
Characteristics of Subsolid Pulmonary Nodules Showing Growth During Follow-up With CT Scanning
Haruhisa Matsuguma et al.
CHEST (2013)
Association of RASSF1A and p63 with Poor Recurrence-Free Survival in Node-Negative Stage I-II Non-Small Cell Lung Cancer
Eunkyung Ko et al.
CLINICAL CANCER RESEARCH (2013)
Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities
Juan Sandoval et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2013)
MAGE qPCR Improves the Sensitivity and Accuracy of EBUS-TBNA for the Detection of Lymphatic Cancer Spread
Beatrix Cucuruz et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
Christoph Kneip et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Do all lung adenocarcinomas follow a stepwise progression?
Yasushi Yatabe et al.
LUNG CANCER (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
DNA Methylation Changes in Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, and Lung Adenocarcinoma
Suhaida A. Selamat et al.
PLOS ONE (2011)
DNA methylation profile during multistage progression of pulmonary adenocarcinomas
Jin-Haeng Chung et al.
VIRCHOWS ARCHIV (2011)
The True False Negative Rates of Esophageal and Endobronchial Ultrasound in the Staging of Mediastinal Lymph Nodes in Patients With Non-Small Cell Lung Cancer
Robert J. Cerfolio et al.
ANNALS OF THORACIC SURGERY (2010)
SHOX2 DNA Methylation is a Biomarker for the Diagnosis of Lung Cancer Based on Bronchial Aspirates
Bernd Schmidt et al.
BMC CANCER (2010)
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients
Lela Buckingham et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer
Monica Castro et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type
Stephen E. Hawes et al.
LUNG CANCER (2010)
Promoter methylation of RASSFIA and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers
Yang Liu et al.
BMC CANCER (2007)
Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers
S Toyooka et al.
CANCER RESEARCH (2006)
Erlotinib in lung cancer - Molecular and clinical predictors of outcome
MS Tsao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: Its prognostic implication and relationship with expression of p53 and Ki-67 proteins
NH Myong
JOURNAL OF KOREAN MEDICAL SCIENCE (2003)
Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer
S Toyooka et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Early peripheral lung cancer:: Prognostic significance of ground glass opacity on thin-section computed tomographic scan
K Suzuki et al.
ANNALS OF THORACIC SURGERY (2002)
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
M Esteller et al.
JOURNAL OF PATHOLOGY (2002)
Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests
M Remy-Jardin et al.
RADIOLOGY (2002)
Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning
K Kodama et al.
LUNG CANCER (2001)
Share Paper
